Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
The arachidonic acid (AA) pathway plays a key role in cardiovascular biology,
carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified …
carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified …
The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives
L Wanka, K Iqbal, PR Schreiner - Chemical reviews, 2013 - ACS Publications
A simple, primary amine bearing a C10H15 alkyl residue was found to display potent anti-
Influenza A properties in 1964. 1 Soon thereafter, antiviral activity of this amine was found …
Influenza A properties in 1964. 1 Soon thereafter, antiviral activity of this amine was found …
Soluble epoxide hydrolase: a potential target for metabolic diseases: 可溶性表氧化物酶: 代谢性疾病的潜在治疗靶点
摘要环氧‐二十碳三烯酸(Epoxyeicosatrienoic acids, EET) 是花生四烯酸的重要代谢产物. EET
在包括动脉粥样硬化, 高血压, 心脏纤维化, 糖尿病, 非酒精性脂肪肝以及肾脏疾病在内的诸多 …
在包括动脉粥样硬化, 高血压, 心脏纤维化, 糖尿病, 非酒精性脂肪肝以及肾脏疾病在内的诸多 …
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
JD Imig, BD Hammock - Nature reviews Drug discovery, 2009 - nature.com
The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation,
antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These …
antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These …
Epoxides and soluble epoxide hydrolase in cardiovascular physiology
JD Imig - Physiological reviews, 2012 - journals.physiology.org
Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that importantly
contribute to vascular and cardiac physiology. The contribution of EETs to vascular and …
contribute to vascular and cardiac physiology. The contribution of EETs to vascular and …
Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products
CP Sun, XY Zhang, C Morisseau… - Journal of medicinal …, 2020 - ACS Publications
Soluble epoxide hydrolase (sEH) is an α/β hydrolase fold protein and widely distributed in
numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively …
numerous organs including the liver, kidney, and brain. The inhibition of sEH can effectively …
Action of epoxyeicosatrienoic acids on cellular function
AA Spector, AW Norris - American Journal of Physiology …, 2007 - journals.physiology.org
Epoxyeicosatrienoic acids (EETs), which function primarily as autocrine and paracrine
mediators in the cardiovascular and renal systems, are synthesized from arachidonic acid by …
mediators in the cardiovascular and renal systems, are synthesized from arachidonic acid by …
Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications
HC Shen, BD Hammock - Journal of medicinal chemistry, 2012 - ACS Publications
1. INTRODUCTION Epoxide hydrolases have been detected in prokaryotes and eukaryotes
ranging from plants to mammals. 1− 3 In mammals these include the soluble epoxide …
ranging from plants to mammals. 1− 3 In mammals these include the soluble epoxide …
The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases
X Xu, XA Zhang, DW Wang - Advanced drug delivery reviews, 2011 - Elsevier
Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid to biologically active
eicosanoids. The primary epoxidation products are four regioisomers of cis …
eicosanoids. The primary epoxidation products are four regioisomers of cis …
Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid–induced inhibition of soluble …
SPB Caligiuri, HM Aukema, A Ravandi, R Guzman… - …, 2014 - Am Heart Assoc
In a randomized, double-blinded, controlled clinical trial, participants with peripheral arterial
disease (75% hypertensive) consumed 30 g of milled flaxseed/d for 6 months. The flaxseed …
disease (75% hypertensive) consumed 30 g of milled flaxseed/d for 6 months. The flaxseed …